A novel Maillard reaction inhibitor containing at least one compound represented by formula (1) and the salts thereof; methods for producing the compounds of formula (1) and the salts thereof; a composition for inhibiting the Maillard reaction in living body comprising at least one compound of formula (1) and the salts thereof; and a use of said compound for preparing a pharmaceutical preparation for inhibiting the Maillard reaction in living body by administration of a compound of formula (1') or a salt thereof are disclosed.
本发明公开了一种新型马氏反应
抑制剂,其中至少含有一种由式(1)代表的化合物及其盐类;生产式(1)化合物及其盐类的方法;一种用于抑制活体内马氏反应的组合物,其中至少含有一种式(1)化合物及其盐类;以及所述化合物的用途,即通过服用式(1')化合物或其盐类制备用于抑制活体内马氏反应的药物制剂。